Cytokine gene variants and venous thrombotic risk in the BRATROS (BRAZILIAN THROMBOSIS STUDY)
Carregando...
Fontes externas
Fontes externas
Data
Orientador
Coorientador
Pós-graduação
Curso de graduação
Título da Revista
ISSN da Revista
Título de Volume
Editor
Elsevier
Tipo
Artigo
Direito de acesso
Acesso restrito
Fontes externas
Fontes externas
Resumo
Introduction: Venous thrombosis (VT) and inflammation are two closely related entities. In the present investigation we assessed whether there is a relation between genetic modifiers of the inflammatory response and the risk of VT. Materials and methods: 420 consecutive and unrelated patients with an objective diagnosis of deep VT and 420 matched controls were investigated. The frequencies of the following gene polymorphisms were determined in all subjects: TNF-α- 308 G/A, LT-α+ 252 A/G, IL-6-174 G/C, IL1-ra 86 bp VNTR, IL-10-1082 A/G and CD-31 125 C/G. Results: Overall odds ratio (OR) for VT related to TNF-α- 308 G/A, LT-α+ 252 A/G, IL-6-174 G/C, A1 allele (4 bp repeat) of the IL1-ra 86 bp VNTR, IL-10-1082 A/G and CD-31 125 C/G were respectively: 1.0 (CI95: 0.8-1.5), 1.3 (CI95: 1.0-1.7), 1.1 (CI95: 0.9-1.5), 1.6 (CI95: 1-2.5), 1.2 (CI95: 0.8-1.7) and 0.8 (CI95: 0.6-1.1). A possible interaction between polymorphisms was observed only for the co-inheritance of the mutant alleles of the LT-α+ 252 A/G and IL-10-1082 G/A polymorphisms (OR = 2; CI95: 1.1-3.8). The risk of VT conferred by factor V Leiden and FII G20210A was not substantially altered by co-inheritance with any of the cytokine gene polymorphisms. Conclusions: Cytokine gene polymorphisms here investigated did not significantly influence venous thrombotic risk. © 2006 Elsevier Ltd. All rights reserved.
Descrição
Palavras-chave
Coagulation , Cytokines , Inflammation , Polymorphisms , Thrombosis , Venous thromboembolism , blood clotting factor 11 , blood clotting factor 5 Leiden , CD31 antigen , cytokine , interleukin 1 receptor blocking agent , interleukin 10 , interleukin 6 , lymphotoxin , tumor necrosis factor alpha , cardiovascular risk , deep vein thrombosis , genetic polymorphism , inflammation , major clinical study , medical research , Base Sequence , Case-Control Studies , DNA Primers , Interleukin 1 Receptor Antagonist Protein , Interleukin-10 , Interleukin-6 , Lymphotoxin-alpha , Middle Aged , Odds Ratio , Polymorphism, Genetic , Tumor Necrosis Factor-alpha , Variation (Genetics) , Venous Thrombosis
Idioma
Inglês
Citação
Thrombosis Research, v. 120, n. 2, p. 221-229, 2007.






